Tumours of the kidney and urinary tract Flashcards
Tumours of the kidney and urinary tract
Introduction
Two types of cancer arise from the renal parenchyma:
- Renal cell carcinomas (also known as renal adenocarcinomas and previously as hypernephromas) are confined to adults
- Nephroblastomas (Wilms’ tumours) are developmental in origin
- present in infancy or early childhood
Renal cell carcinoma
Histological classification of adult renal tumours of the Union Internationale Contre le Cancer (UICC):
A. Malignant:
- Conventional clear cell carcinoma (70–80%)
- Papillary or tubulo-papillary renal carcinoma (10–15%)
- Chromophobe renal carcinoma (5%)
- Collecting duct carcinoma (rare)
B. Benign:
- Oncocytoma
- Papillary or tubular adenoma
- Angiomyolipoma (may be neoplastic or hamartomatous)
Renal cell carcinoma
Pathology of renal cell carcinoma
- originates in renal tubules
- Tumour cells are characteristically large and polygonal, with clear cytoplasm representing accumulation of glycogen and lipid
- known pathologically as clear cell carcinomas
- Advanced renal cell carcinoma characteristically extends into the lumen of the renal vein and into the inferior vena cava
- spread is typically to lung, liver and bone. Lung metastases are often typical discrete ‘cannonball secondaries’
Renal cell carcinoma
Staging of renal cell carcinoma
- Stage I tumours are confined by the renal capsule;
- stage II tumours have penetrated the renal capsule but remain confined by Gerota’s perinephric fascia;
- stage III tumours have renal vein involvement or nodal spread;
- stage IV have distant metastases.
Renal cell carcinoma
Clinical features of renal cell carcinoma
- triad of haematuria, a mass and flank pain;
- diagnosis is made incidentally by discovering a tumour on ultrasonography or CT scanning
- Renal cell carcinomas often become large before diagnosis owing to their retroperitoneal position
Uncommon presentations:
- Iron deficiency anaemia
- Polycythaemia due to erythropoietin production
- Hypertension due to renin production
- Hypercalcaemia due to parathormone-like protein production
- Pyrexia of unknown origin
- Elevated erythrocyte sedimentation rate
- Secondary lesions (e.g. ‘cannonball’ lesions on chest X-ray, pathological fractures)
Urothelial carcinoma (transitional cell carcinoma)
- Tumours of urothelium are common
- Histologically, they are nearly all urothelial carcinomas (UCs); other than rarities, the rest are squamous cell carcinomas (7%) or adenocarcinomas (1%)
- Most arise primarily in the bladder but they also occur in the pelvicalyceal system and ureters and rarely in the urethra
- Men are affected three times more often than women. UC is at least four times more common than renal cell carcinoma.
- Cigarette smoking is associated with a four-fold increase in incidence of urothelial tumours; this is probably mediated by urinary excretion of inhaled carcinogens
- strongly associated with exposure to industrial carcinogens, once widely used in the rubber, cable, dye and printing industries
Urothelial carcinoma
Clinical features of urothelial carcinoma
- presents with painless haematuria
- Very occasionally, an upper tract lesion may cause ureteric colic (clot colic) and long stringy clots are seen in the urine
- If bleeding is gross, clots may cause ureteric obstruction. Rapid bleeding from a bladder tumour may cause clot retention, i.e. acute retention of urine due to clot obstruction
- predispose to infection; unexplained recurrent urinary tract infections need investigating to exclude UC as a cause
Urothelial carcinoma
Staging of urothelial tumours of the bladder
- Staging is achieved mainly by cystoscopic examination and palpation under anaesthesia, combined with histological examination of resected specimens.
- TNM clinical system widely used in staging bladder tumours
Urothelial carcinoma
Management of urothelial carcinoma
Bladder Tumours
- Urothelial carcinomas of bladder - diff morphological types, from small, discrete, multiple, frond-like lesions through to extensive papilliferous or flat tumours
- Four-quadrant biopsy of the rest of the bladder can help formulate a treatment plan and estimate prognosis
- If papillary tumours coexist with carcinoma-in-situ (CIS), long-term prognosis is poor
- treated by immunotherapy with a course of intravesical BCG to stimulate local immunity
- if CIS persists, then total cystectomy is the treatment of choice
- complete removal of tumour tissue by cystoscopic transurethral resection of bladder tumour (TURBT)
Urothelial carcinoma
Management of urothelial carcinoma
Urothelial tumours of the upper tract
- Treatment usually requires excision of the whole upper tract on the affected side including kidney, ureter and a cuff of bladder wall surrounding the distal ureter.
- However, some small, isolated renal pelvic tumours can be dealt with endoscopically via a nephroscope passed percutaneously into the pelvicalyceal system or by laser ablation via a fibreoptic flexible ureteroscope